Abstract:Background Neuroinflammation is an important host defense response to secondary brain injury after intracerebral hemorrhage (ICH). Triggering receptor expressed on myeloid cells 2 (TREM2) confers strong neuroprotective effects by attenuating neuroinflammation in experimental ischemic stroke. Recent studies suggest that apolipoprotein E (apoE) is a novel, high-affinity ligand of TREM2. This study aimed to investigate the effects of TREM2 activation on neuroinflammation and neuronal apoptosis in a mouse model of ICH. Methods Adult male CD1 mice (n = 216) were subjected to intrastriatal injection of bacterial collagenase. The TREM2 ligand, apoE-mimetic peptide COG1410 was administered intranasally at 1 h after ICH induction. To elucidate the underlying mechanism, TREM2 small interfering RNA (siRNA) and the phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 were administered intracerebroventricularly prior to COG1410 treatment. Neurobehavioral tests, brain water content, immunofluorescence, western blotting, and Fluoro-Jade C- and terminal deoxynucleotidyl transferase dUTP nick end labeling staining were performed. Results Endogenous TREM2 expression was increased and peaked at 24 h after ICH. TREM2 was expressed on microglia, astrocytes, and neurons. COG1410 improved both short-term and long-term neurological functions, reduced brain edema, inhibited microglia/macrophage activation and neutrophil infiltration, and suppressed neuronal apoptotic cell death in perihematomal areas after ICH. Knockdown of endogenous TREM2 by TREM2 siRNA aggravated neurological deficits and decreased the expression of TREM2 in naive and ICH mice. COG1410 was associated with upregulation of TREM2, PI3K, phosphorylated-Akt, and Bcl-2 and downregulation of TNF-alpha, IL-1 beta, and Bax after ICH. The neuroprotective effects of COG1410 were abolished by both TREM2 siRNA and PI3K inhibitor LY294002. Conclusions Our finding demonstrated that TREM2 activation improved neurological functions and attenuated neuroinflammation and neuronal apoptosis after ICH, which was, at least in part, mediated by activation of PI3K/Akt signaling pathway. Therefore, activation of TREM2 may be a potential therapeutic strategy for the management of ICH patients.

Triggering receptor expressed on myeloid cells 2 in synovial tissue of rheumatoid arthritis rats

Identification and Validation of TREM2 in Intracranial Aneurysms

Expression of TREM-2 and Its Inhibitory Effects on TNF-α Induced Inflammation in Fibroblast-Like Synoviocytes Via Inhibiting P38 Pathway Activation.

Triggering receptor expressed on myeloid cells-2 protects against polymicrobial sepsis by enhancing bacterial clearance.

TREM2 promotes macrophage polarization from M1 to M2 and suppresses osteoarthritis through the NF-κB/CXCL3 axis

TREM2 Activation Attenuates Neuroinflammation and Neuronal Apoptosis Via PI3K/Akt Pathway after Intracerebral Hemorrhage in Mice.

Activation of triggering receptor expressed on myeloid cells-1 protects monocyte from apoptosis through regulation of myeloid cell leukemia-1.

Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) Elicited by Lung Cancer Cells to Facilitate Tumor Immune Evasion.

[Temporal Expression of Triggering Receptors Expressed by Myeloid Cells-1 During the Development of Experimental Periodontitis in Rat].

Expression of Triggering Receptor-1 in Myeloid Cells of Mice with Acute Lung Injury.

Advance of TREM-1 and Its Role in Sepsis

Current understanding on TREM-2 molecular biology and physiopathological functions

TREM-2 Negatively Regulates LPS-mediated Inflammatory Response in Rat Bone Marrow-Derived MSCs

Research Advances on TREM-1 Function and Signal Pathway in Pathogenesis

Triggering receptor expressed on myeloid Cells-2 (TREM2) inhibits steroidogenesis in adrenocortical cell by macrophage-derived exosomes in lipopolysaccharide-induced septic shock.

Expression of Triggering Receptor Expressed on Myeloid Cells-1 in Lung Tissue of Rats with Acute Lung Injury Induced by Lipopolysaccharide and Its Relationship with Endoplasmic Reticulum Stress and Inflammatory Response

Increased expression of triggering receptor expressed on myeloid cells 1 and 2 in inflamed human gingiva

sTREM2 Differentially Affects Cytokine Expression in Myeloid-Derived Cell Models via MAPK–JNK Signaling Pathway

Expression and significance of TREM-1 in neonatal rats with intrauterine infection

TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses.

Regulation Of Trem2 Expression By An Nf-Kappa B-Sensitive Mirna-34a